Concepedia

Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy

Daisuke Ennishi, Masaru Yokoyama, Y. Terui, Hiroaki Asai, Sakura Sakajiri, Yuko Mishima, Shunji Takahashi, Hirotake Komatsu, Kazuma Ikeda, Kengo Takeuchi,

Annals of Oncology · 2008 · 60 citations · 27 references

DOIFull text

Open access

Concepts

References

27

World Health Organization Classification of Tumours

CDM Fletcher, Anke van den Berg, Ineke Molenaar · 2002 · 7.1K citations

, , +11

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

Bertrand Coiffier, Éric Lepage, Josette Brière et al. · New England Journal of Medicine · 2002 · 5.6K citations · Full text

, , +9

A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

New England Journal of Medicine · 1993 · 5K citations · Full text

, , +15

World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues

D. K. Hossfeld · Annals of Oncology · 2002 · 4.6K citations · Full text

, , +14

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Christine P. Hans · Blood · 2003 · 4.3K citations · Full text

, , +16